Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.ejphar.2020.173328

http://scihub22266oqcxt.onion/10.1016/j.ejphar.2020.173328
suck pdf from google scholar
32603692!7320862!32603692
unlimited free pdf from europmc32603692    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32603692      Eur+J+Pharmacol 2020 ; 882 (ä): 173328
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Current pharmacological treatments for SARS-COV-2: A narrative review #MMPMID32603692
  • Nittari G; Pallotta G; Amenta F; Tayebati SK
  • Eur J Pharmacol 2020[Sep]; 882 (ä): 173328 PMID32603692show ga
  • The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. Despite the knowledge of previous coronaviruses, such as those responsible for the SARS and MERS-CoV epidemic, there is no drug or prophylaxis treatment to this day. The rapid succession of scientific findings on SARS-CoV-2 provides a significant number of potential drug targets. Nevertheless, at the same time, the high quantity of clinical data, generated by a large number of rapidly infected people, require accurate tests regarding effective medical treatments. Several in vitro and in vivo studies were rapidly initiated after the outbreak of the pandemic COVID-19. Initial clinical studies revealed the promising potential of remdesivir that demonstrated a powerful and specific in vitro antiviral activity for COVID-19. Promising effects appear to be attributable to hydroxychloroquine. Remdesivir and hydroxychloroquine are being tested in ongoing randomized trials. In contrast, oseltamivir was not effective and corticosteroids are not currently recommended. However, few data from ongoing clinical trials are identifying low molecular weight heparins, innate immune system stimulating agents, and inflammatory modulating agents as potential effective agents. The authors assume that the current pandemic will determine the need for a systematic approach based on big data analysis for identifying effective drugs to defeat SARS-Cov-2. This work is aimed to be a general reference point and to provide an overview as comprehensive as possible regarding the main clinical trials in progress at the moment.
  • |Adenosine Monophosphate/analogs & derivatives/pharmacology/therapeutic use[MESH]
  • |Adjuvants, Immunologic/*pharmacology/therapeutic use[MESH]
  • |Alanine/analogs & derivatives/pharmacology/therapeutic use[MESH]
  • |Antiviral Agents/*pharmacology/therapeutic use[MESH]
  • |Betacoronavirus/*drug effects/immunology/pathogenicity[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Coronavirus Infections/*drug therapy/epidemiology/virology[MESH]
  • |Glucocorticoids/pharmacology/therapeutic use[MESH]
  • |Heparin, Low-Molecular-Weight/pharmacology/therapeutic use[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/pharmacology/therapeutic use[MESH]
  • |Immunity, Innate/drug effects[MESH]
  • |Inflammation Mediators/*pharmacology/therapeutic use[MESH]
  • |Oseltamivir/pharmacology/therapeutic use[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy/epidemiology/virology[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box